5-HT in the enteric nervous system : gut function and neuropharmacologyMCLEAN, Peter G; BORMAN, Richard A; LEE, Kevin et al.Trends in neurosciences (Regular edition). 2007, Vol 30, Num 1, pp 9-13, issn 0166-2236, 5 p.Article

Kinin B₁ receptors and the cardiovascular system : regulation of expression and functionMCLEAN, Peter G; PERRETTI, Mauro; AHLUWALIA, Amrita et al.Cardiovascular research. 2000, Vol 48, Num 2, pp 194-210, issn 0008-6363Article

Validation of a conscious rat model for the discovery of novel agents that inhibit gastric acid secretionCAMPBELL, Colin A; GASKIN, Pamela J; DARTON, Jill et al.European journal of pharmacology. 2008, Vol 589, Num 1-3, pp 260-263, issn 0014-2999, 4 p.Article

Dual role of 5-HT₃ receptors in a rat model of delayed stress-induced visceral hyperalgesiaBRADESI, Sylvie; LIJUN LAO; MCLEAN, Peter G et al.Pain (Amsterdam). 2007, Vol 130, Num 1-2, pp 56-65, issn 0304-3959, 10 p.Article

Effects of the 5-HT3 receptor antagonist, alosetron, in a rat model of somatic and visceral hyperalgesiaMIRANDA, Adrian; PELES, Shachar; MCLEAN, Peter G et al.Pain (Amsterdam). 2006, Vol 126, Num 1-3, pp 54-63, issn 0304-3959, 10 p.Article

Protease-activated receptor-2 activation causes EDHF-like coronary vasodilation: Selective preservation in ischemia/reperfusion injury: Involvement of lipoxygenase products, VR1 receptors, and C-fibersMCLEAN, Peter G; ASTON, Daniel; SARKAR, David et al.Circulation research. 2002, Vol 90, Num 4, pp 465-472, issn 0009-7330Article